Product Program year 2025 Source: CMS Open Payments

Definity

Drug Contrast Agent

NDC 11994-011-01

Open in the dashboard

General payments

$3,933,929

14,808 payments

Research payments

$3,854,804

512 payments

Through program year 2025, $3,933,929 in general payments and $3,854,804 in research payments were reported against Definity (Contrast Agent).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

14 rows
Year Kind Amount Payments
2025 General $327,592 1,380
2025 Research $241,735 36
2024 General $414,304 2,079
2024 Research $121,148 20
2023 General $589,287 2,661
2023 Research $331,414 36
2022 General $663,077 2,427
2022 Research $301,740 33
2021 General $500,816 1,971
2021 Research $192,552 47
2020 General $456,605 1,279
2020 Research $690,745 110
2019 General $982,249 3,011
2019 Research $1,975,470 230

Breakdown

Who paid General payments · program years 2019–2025
  1. Lantheus Medical Imaging, Inc. $3,933,929 14,808 payments
Top recipients General payments · program year 2025
  1. Eyal Herzog Cardiovascular Disease · New York, NY $53,575 16% · 50 payments
  2. Kristina Gibson Nurse Practitioner, Acute Care · Murray, UT $39,639 12% · 46 payments
  3. Steven Mottl Cardiovascular Disease · Tucson, AZ $38,379 12% · 28 payments
  4. Rajesh Janardhanan Internal Medicine · Tucson, AZ $17,459 5% · 14 payments
  5. Frederman Concepcion Cardiovascular Disease · Chicago, IL $16,529 5% · 10 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Cardiovascular Disease Internal Medicine $168,235 65% · 353 practitioners
  2. Nurse Practitioner, Acute Care Nurse Practitioner $40,623 16% · 39 practitioners
  3. Internal Medicine $20,039 8% · 90 practitioners
  4. Interventional Cardiology Internal Medicine $15,337 6% · 66 practitioners
  5. Hematology & Oncology Internal Medicine $2,424 <1% · 1 practitioner

The top 5 of 40 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Arizona $60,840 19% · 10 recipients
  2. New York $59,667 18% · 118 recipients
  3. Utah $53,719 16% · 8 recipients
  4. Illinois $35,005 11% · 56 recipients
  5. California $21,643 7% · 80 recipients

The top 5 of 45 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

Given in the clinic

Part B · billing code
Medicare Part B billing codes matched to DEFINITY
Billing code Providers Services Paid by Medicare
Injection, perflutren lipid microspheres, per ml Q9957 1,184 72,795 $2,340,893

Drugs given by a clinician are billed to Medicare Part B, not Part D. The product is tied to a billing code through the NDC on CMS's crosswalk, which was published for a later quarter than the payments, so a code that changed in between can be missed. Providers with fewer than 11 patients for the code are not published. Medicare's payment here is what it paid for the services, to the billing practice.

14,808 general · 512 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record